Background illustration for clinical trials search

Paid Clinical Trials Naperville

Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,409

Effects of Exercise and 5-HTP on Cortisol Levels

for

Plasma Cortisol

Location: Lisle IL

Sponsor: Benedictine University

Sex: All

Age: 18 - 60

Code: NCT02187341

Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

for

Heart Failure

Location: Naperville IL, Glenview IL, Island Lake IL,

Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06024746

Phase 3, Recruiting

Active & Responsive

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

for

Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome,

Location: Elk Grove Village IL, Chicago IL, Detroit MI,

Sponsor: Procyrion

Sex: All

Age: 21+

Code: NCT05677100

Not recruiting

Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for

Chronic Lymphocytic Leukemia

Location: Dyer IN, Springfield IL, Detroit MI, Des Moines IA,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase 3, Recruiting

Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for

Non-Small Cell Lung Cancer,

Location: Chicago IL, Grand Rapids MI, Fort Wayne IN,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase 1, Recruiting

Featured

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

for

Healthy Volunteers

Location: Grayslake IL

Sponsor: AbbVie

Sex: All

Age: 18 - 60

Code: NCT07306754

Phase 1, Recruiting

FeaturedActive & Responsive

A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants

for

Healthy Volunteer

Location: Grayslake IL, Anaheim CA

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07736638

Phase 1, Recruiting

FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for

Generalized Anxiety Disorder (GAD)

Location: Chicago IL, St Louis MO, Saint Charles MO, O'Fallon MO,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase 2, Recruiting

FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for

Bipolar I Disorder, Bipolar II Disorder

Location: Warrenville IL, Chicago IL, Saint Charles MO,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase 2, Recruiting

FeaturedActive & Responsive

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for

Major Depressive Disorder

Location: Warrenville IL, Chicago IL, Columbus OH, Avon Lake OH,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07276997

Phase 2, Recruiting

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

for

Rotator Cuff Injuries

Location: Rockford IL, Hamilton, Pittsburgh PA, Rome GA, Calgary

Sponsor: Smith & Nephew, Inc.

Sex: All

Age: 18+

Code: NCT05444465

Recruiting

Parent SMART (Substance Misuse in Adolescents in Residential Treatment)

for

Substance Use, Adolescent Behavior

Location: Rockford IL, Plymouth MN

Sponsor: Brown University

Sex: All

Age: 12 - 18

Code: NCT05169385

Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for

Hematologic Malignancies

Location: Zion IL, Birmingham AL, Greenville SC, Newnan GA,

Sponsor: Sellas Life Sciences Group

Sex: All

Age: 12+

Code: NCT04588922

Phase 1, Phase 2, Recruiting

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

for

Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

Location: Zion IL, Newnan GA, Goodyear AZ, Duarte CA

Sponsor: VIVUS LLC

Sex: All

Age: 18+

Code: NCT06915246

Phase 2, Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for

Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)

Location: Zion IL, Detroit MI, Louisville KY, Columbus OH,

Sponsor: J-Pharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07265674

Phase 3, Recruiting

C-Brace Prospective Registry

for

Pareses, Lower Extremity

Location: Merrillville IN, Green Bay WI, Lansing MI,

Sponsor: Otto Bock Healthcare Products GmbH

Sex: All

Age: 0+

Code: NCT04640584

Recruiting

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

for

Dry Eye

Location: Lake Villa IL, Chesterfield MO

Sponsor: Innovative Medical

Sex: All

Age: 18+

Code: NCT01386073

Recruiting

New

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

for

Anatomic Stage IV Breast Cancer AJCC v8,

Location: Ottawa IL, Peru IL, Princeton IL, Bloomington IL,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07578116

Phase 3, Recruiting

New

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Ottawa IL, Peru IL, Princeton IL, Bloomington IL,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07393555

Phase 2, Recruiting

New

Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial

for

Richter Syndrome,

Location: Ottawa IL, Peru IL, Princeton IL, Mukwonago WI,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07220187

Phase 3, Recruiting

Paid Clinical Trials Naperville

Filter results

Effects of Exercise and 5-HTP on Cortisol Levels

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Interested in new trials?

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

Parent SMART (Substance Misuse in Adolescents in Residential Treatment)

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

C-Brace Prospective Registry

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial